-+ 0.00%
-+ 0.00%
-+ 0.00%

Relmada CFO Maged Shenouda acquires $843,140 of common shares

PUBT·09/11/2026 11:30:44
Listen to the news
Relmada CFO Maged Shenouda acquires $843,140 of common shares
  • Relmada Therapeutics CFO Maged Shenouda bought 200,000 common shares in open-market purchases at about $4.20–$4.25 each.
  • His directly held stake rose to 1,000,000 common shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relmada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-098970), on September 11, 2026, and is solely responsible for the information contained therein.